NCT00598585View on ClinicalTrials.gov

Use of Sildenafil (Viagra) to Alter Fatigue, Functional Status and Impaired Cerebral Blood Flow in Patients With CFS

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Chronic Fatigue Syndrome
Interventions
DRUG

Sildenafil (Viagra)

25 mg tid of either Sildenafil(Viagra) for first week. 50 mg tid of either Sildenafil (Viagra) for second week. 100 mg tid of either Sildenafil (Viagra) 3rd,4th, 5th and 6th week of study participation.

DRUG

Placebo

Placebo pills 3X/day for 6 weeks

Trial Locations (1)

90059

Charles Drew University of Medicine and Science, Los Angeles

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Charles Drew University of Medicine and Science

OTHER